Use of ADHD medication in UK more than tripled in 13 years, study finds
The proportion of people in the UK on attention deficit hyperactivity disorder (ADHD) medication has tripled in the past decade, with a 20-fold increase among women aged 25 and over, a study shows.
Researchers led by the University of Oxford examined electronic health records from Belgium, Germany, the Netherlands, Spain and the UK to estimate the use of ADHD medication among adults and children aged three and above.
Prevalence increased across all five countries between 2010 and 2023, according to the research. The UK had the highest relative increase for all ages, rising more than threefold from 0.12% to 0.39%. In the Netherlands, prevalence more than doubled, from 0.67% to 1.56%.
Adult use increased substantially in all countries, particularly among women. In the UK, prevalence among people aged 25 and over increased from 0.01% in 2010 to 0.20% in 2023, with a more than 20-fold increase in women and 15-fold in men.
Although ADHD medication use remained higher among males, the sex gap in treatment narrowed over time and with increasing age, the researchers said.
“We observed a consistent increase in ADHD medication use across Europe, but the most striking changes were among adults, especially women,” said Xintong Li, the lead study author at Oxford. “These findings likely reflect growing awareness and diagnosis of adult ADHD, but they also raise important questions about long-term treatment patterns and care needs.”
Source: The Guardian, 21 January 2026